Celsion Corp (NASDAQ:CLSN)

2.18
Delayed Data
As of Feb 23
 -0.07 / -3.11%
Today’s Change
1.24
Today|||52-Week Range
6.06
-18.66%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$35.0M

Company Description

Celsion Corp. is an oncology drug development company. It focuses on developing a portfolio of innovative cancer treatments, including directed chemotherapies, DNA-mediated immunotherapy and RNA- based therapies. The company's products include ThermoDox and GEN-1. Celsion was founded by Yim-Pan Cheung in 1982 and is headquartered in Lawrenceville, NJ.

Contact Information

Celsion Corp.
997 Lenox Drive
Lawrenceville New Jersey 08648
P:(609) 896-9100
Investor Relations:
(609) 482-2455

Employees

Shareholders

Other institutional6.62%
Mutual fund holders2.67%
Individual stakeholders0.30%

Top Executives

Michael H. TardugnoExecutive Chairman, President & CEO
Jeffrey Wayne ChurchCFO, Secretary & SVP-Investor Relations
Nicholas BorysChief Medical Officer & Vice President
Khursheed AnwerChief Scientific Officer & Executive VP
Jason FewellVice President-Preclinical Research